8428
S. Kobayashi et al. / Tetrahedron 63 (2007) 8425–8429
the powdered Hf catalyst (0.040 mmol), and the mixture was
used for the reaction.
d 0.81 (d, 3H, J¼6.4 Hz), 0.88 (d, 3H, J¼6.6 Hz), 1.26 (t,
3H, J¼7.4 Hz), 1.35 (dd, 2H, J¼6.6, 7.7 Hz), 1.63 (7, 1H,
J¼6.7 Hz), 2.25 (s, 3H), 2.64 (dd, 1H, J¼8.0, 15.9 Hz),
2.80 (dd, 1H, J¼4.2, 15.8 Hz), 2.92 (q, 2H, J¼7.5 Hz),
3.62 (dq, 1H, J¼4.2, 7.1 Hz), 6.66 (dd, 1H, J¼0.6,
7.4 Hz), 6.76 (dd, 1H, J¼1.4, 7.8 Hz), 6.88 (t, 1H,
J¼7.7 Hz). 13C NMR (CDCl3): d 14.6, 18.1, 22.0, 23.2,
23.6, 25.1, 44.5, 48.4, 52.5, 113.3, 121.8, 124.6, 131.2,
132.5, 151.9, 200.3. HPLC: Daicel Chiralpak OD,
hexane/iPrOH¼60/1, flow rate¼1.0 mL/min, tR¼14.9 min
(3S), tR¼17.2 min (3R).
4.4.2.1. Methyl 2,20-dimethyl-3-(2-hydroxyphenyl)-
amino-3-(10-naphthyl)propionate.4f Mp 135–136 ꢀC. IR
1
(neat): 3052, 1691, 1604, 1578, 1270, 798 cmꢁ1. H NMR
(CDCl3): d 1.18 (s, 3H), 1.25 (s, 3H), 3.66 (s, 3H), 5.62 (s,
3H), 6.28–6.62 (m, 4H), 7.22–8.00 (m, 7H). 13C NMR
(CDCl3): d 19.9, 25.1, 48.4, 52.4, 57.8, 113.4, 114.2,
117.9, 121.2, 122.1, 123.2, 125.2, 125.3, 125.4, 126.1,
128.1, 129.1, 133.6, 135.3, 135.5, 144.1, 177.9. HPLC: Dai-
cel Chiralcel OD, hexane/iPrOH¼19/1, flow rate¼0.8 mL/
min, tR¼25.8 min (3S), tR¼29.0 min (3R).
4.5. Preparation of the single crystals
4.4.2.2. Methyl 2,20-dimethyl-(2-hydroxyphenyl)-
The powdered Hf catalyst containing N-benzylimidazole
(20 mg) was dissolved in AcOEt (2 mL). This solution was
allowed to stand in a sealed vial filled with hexane. After
standing the solution for 1 day, colorless single crystals
were formed.
amino-3-phenylpropionate.4f
Mp 112.5–114 ꢀC. IR
(KBr): 3401, 1709, 1611, 1514, 1453, 1391 cmꢁ1 1H
.
NMR (CDCl3): d 1.21 (s, 3H), 1.24 (s, 3H), 3.68 (s, 3H),
4.57 (s, 1H), 6.36–6.76 (m, 4H), 7.21–7.28 (m, 5H). 13C
NMR (CDCl3): d 19.9, 24.2, 47.3, 52.3, 64.3, 113.2, 114.1,
117.6, 120.8, 127.3, 127.9, 128.3, 135.6, 138.9, 144.0,
178.0. HPLC: Daicel Chiralpak AD, hexane/iPrOH¼9/1,
flow rate¼1.0 mL/min, tR¼9.3 min (3R), tR¼16.0 min (3S).
4.5.1. Crystal data of Hf crystal. C136H92Br12Hf4O24:
Fw¼3783.02, Dcalcd (g cmꢁ3)¼1.566, crystal system¼cubic,
˚
˚
space group¼F432, a(A)¼31.7745(8), b(A)¼31.7745(8),
˚
c(A)¼31.7745(8), a(deg)¼90.000, b(deg)¼90.000, g(deg)¼
3
o
˚
˚
4.4.2.3. S-Ethyl 3-(2-hydroxyphenyl)amino-3-phenyl-
propanethioate.4f Mp 79.5–80.5 ꢀC. IR (KBr): 3396,
90.000, V(A )¼32080.3(14), Z¼8, T( C)¼–180, l(A)¼
0.7107, R factor [all data]¼0.0472, R1 factor [I>2.0
s(I)]¼0.0428, Rw factor [all data]¼0.1362, goodness of
fit¼1.136.
1
1647, 1608, 1520, 1449, 1362 cmꢁ1. H NMR (CDCl3):
d 1.67 (t, 3H, J¼7.3 Hz), 2.83 (q, 2H, J¼7.3 Hz), 2.97 (dd,
1H, J¼5.4, 14.9 Hz), 3.07 (dd, 1H, J¼8.1, 14.9 Hz), 4.81
(dd, 1H, J¼5.4, 8.1 Hz), 6.44–6.71 (m, 4H), 7.20–7.33
(m, 5H). 13C NMR (CDCl3): d 14.4, 23.6, 51.4, 56.1,
114.4, 114.6, 118.8, 121.1, 126.3, 127.4, 128.6, 134.9,
141.7, 144.7, 198.4. HPLC: Daicel Chiralpak AS,
hexane/iPrOH¼19/1, flow rate¼1.0 mL/min, tR¼26.6 min
(3S), tR¼38.2 min (3R).
4.6. Procedure for asymmetric Mannich-type
reactions using single crystals
4.6.1. Without NMI. The crystal Hf catalyst (8.6 mg,
0.010 mmol) was suspended in dichloromethane
(0.25 mL). After the mixture was stirred for 1 h at room
temperature, aldimine (0.10 mmol) and silicon enolate
(0.12 mmol) in dichloromethane (0.25 mL) were added at
–45 ꢀC. The reaction mixture was stirred for 132 h, and hex-
ane (10 mL) was added to quench the reaction. Precipitates
were formed, which were removed by filtration. The filtrate
was concentrated and treated with THF–1 M HCl (10:1) at
0 ꢀC for 1 h. The solution was then basicified with a saturated
aqueous NaHCO3 solution, and the aqueous solution was
extracted with CH2Cl2. The organic layer was dried over
anhydrous Na2SO4. After filtration and concentration under
reduced pressure, the crude product was purified by pre-
parative thin layer chromatography to afford the desired
product.
4.4.2.4. S-Ethyl 3-(2-hydroxyphenyl)amino-3-(10-
naphthyl)propane thioate.4f Mp 40.5–41.5 ꢀC. IR (KBr):
3380, 1645, 1605, 1514, 1446, 1362 cmꢁ1 1H NMR
.
(CDCl3): d 1.18 (t, 3H, J¼7.3 Hz), 2.86 (q, 2H, J¼7.3 Hz),
3.03 (dd, 1H, J¼9.4, 14.8 Hz), 3.20 (dd, 1H, J¼3.3,
14.8 Hz), 5.68–5.70 (m, 1H), 6.30–6.71 (m, 4H), 7.29–8.23
(m, 7H). 13C NMR (CDCl3): d 14.4, 23.7, 50.7, 51.9,
113.5, 114.4, 118.1, 121.3, 122.1, 123.1, 125.6, 125.7,
126.5, 128.0, 129.2, 130.3, 134.0, 135.3, 136.7, 143.9,
198.5. HPLC: Daicel Chiralpak AD, hexane/iPrOH¼9/1,
flow rate¼1.0 mL/min, tR¼15.5 min (3S), tR¼21.0 min (3R).
4.4.2.5. S-Ethyl 3-(40-chlorophenyl)-3-[(20-hydroxy-
phenyl)amino]propanethioate.4f IR (neat): 3412, 1665,
4.6.2. With NMI. N-Methylimidazole (1.64 mg,
0.02 mmol) was added to a white suspension of crystals of
the Hf catalyst (8.6 mg, 0.010 mmol) in dichloromethane
(0.25 mL). After stirring for 3 h, the crystals were partially
dissolved, and the slightly suspended mixture was used for
the reaction.
1
1610, 1516, 1447, 742 cmꢁ1. H NMR (CDCl3): d 1.21 (t,
2H, J¼7.4 Hz), 2.87 (q, 2H, J¼7.4 Hz), 2.96 (dd, 1H,
J¼5.1, 14.9 Hz), 3.05 (dd, 1H, J¼8.3, 14.9 Hz), 4.78 (dd,
1H, J¼5.1, 8.3 Hz), 6.39–6.78 (m, 4H), 7.22–7.28 (m,
4H). 13C NMR (CDCl3): d 14.5, 23.7, 51.2, 55.6, 114.5,
115.0, 119.3, 121.2, 127.8, 128.9, 133.2, 134.6, 140.3,
144.7, 197.8. HPLC: Daicel Chiralpak AD, hexane/iPrOH¼
9/1, flow rate¼1.0 mL/min, tR¼19.5 min (3S), tR¼24.3 min
(3R).
Acknowledgements
This work was partially supported by Grant-in-Aid for Sci-
entific Research from the Japan Society of the Promotion
of Sciences (JSPS). We thank Mr. Yoshiki Hasegawa for
his contribution to the early stage of this work.
4.4.2.6.
S-Ethyl
3-[(2-hydroxy-6-methylphenyl)-
amino]-5-methylhexanethioate.4f IR (neat): 3356, 2957,
2871, 1681, 1588, 1472, 1366 cmꢁ1. H NMR (CDCl3):
1